Skip to main content

Table 2 Clinical characteristic of 72 patients with “grey zone PSA” values who underwent prostate biopsy

From: Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria

 

Number

Age (years)

PSA (ng/ml)

Prostate volume (mls)

BPH patients with intermediate PSA

57

66.25 ± 9.96

5.41 ± 1.77

102.93 ± 87.75

CAP patients with intermediate PSA

15

65.57 ± 20.55

7.06 ± 1.95

96.12 ± 52.42

T test

 

P = 0.86

P = 0.002*

P = 0.78

  1. *P < 0.05 statistically significant